IPN-10260

N/A

Report date: 2025/06/11 11:12:24

Base Information

Drug NameIPN-10260
Drug Alias NamerBoNT/A1
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Toxin
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsNeuromuscular Blocking Agents
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIpsen BioInnovation Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIpsen BioInnovation LtdUniversity Of Glasgow
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A